US Medicare's new 'Most-Favored-Nation' pricing policy could raise international medicine prices
A new modeling study published in The Lancet suggests that US Medicare’s new ‘Most-Favored-Nation’ pricing policy, which ties what Medicare pays for medicines to prices charged in other high-income countries,…